Patents by Inventor K. Ranga Krishnan

K. Ranga Krishnan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEBORRHEA
    Publication number: 20090148541
    Abstract: Methods and compositions are provided for treating dermatological diseases, disorders, and pathologies, including seborrheic dermatitis, in a subject in need thereof. In some embodiments, methods are provided for the treatment of a dermatological disease, disorder, or pathology comprising, topically administering to a subject in need of dermatological treatment a composition comprising a therapeutically effective amount of bupropion, lithium or lithium salicylate, or combinations thereof.
    Type: Application
    Filed: October 16, 2008
    Publication date: June 11, 2009
    Applicant: Duke University
    Inventor: K. Ranga Krishnan
  • COMPOSITIONS OF AN ANTICONVULSANT AND AN ANTIPSYCHOTIC DRUG AND METHODS OF USING THE SAME FOR AFFECTING WEIGHT LOSS
    Publication number: 20090018115
    Abstract: Disclosed are compositions for affecting weight loss comprising a first compound and a second compound, where the first compound is a psychotherapeutic agent and the second compound is a anticonvulsant. Also disclosed are methods of affecting weight loss, increasing energy expenditure, increasing satiety in an individual, or suppressing the appetite of an individual, comprising identifying an individual in need thereof and treating that individual with a psychotherapeutic agent and an anticonvulsant.
    Type: Application
    Filed: September 26, 2008
    Publication date: January 15, 2009
    Applicant: Orexigen Therapeutics, Inc.
    Inventors: Kishore M. Gadde, K. Ranga Krishnan
  • Method for treating obesity
    Publication number: 20060009514
    Abstract: The present invention relates, in general, to obesity, and, in particular, to a method of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide or other weight-loss promoting anticonvulsant either alone or in combination with bupropion or other compound that enhances the activity of norepinephrine and/or dopamine via uptake inhibition or other mechanism.
    Type: Application
    Filed: September 7, 2005
    Publication date: January 12, 2006
    Inventors: Kishore Gadde, K. Ranga Krishnan
  • Method for treating obesity
    Publication number: 20050215552
    Abstract: The present invention relates generally to methods of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide or other weight loss-promoting anti-convulsant either alone or in combination with bupropion or metabolites thereof or other compound that enhances the activity of norepinephrine and/or dopamine via uptake inhibition or other mechanism.
    Type: Application
    Filed: February 15, 2005
    Publication date: September 29, 2005
    Inventors: Kishore Gadde, K. Ranga Krishnan
  • Method for treating obesity
    Publication number: 20050143322
    Abstract: The present invention relates, in general, to obesity, and, in particular, to a method of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide or other weight-loss promoting anticonvulsant either alone or in combination with bupropion or other compound that enhances the activity of norepinephrine and/or dopamine via uptake inhibition or other mechanism.
    Type: Application
    Filed: February 15, 2005
    Publication date: June 30, 2005
    Inventors: Kishore Gadde, K. Ranga Krishnan
  • Method for treating obesity
    Publication number: 20050137144
    Abstract: The present invention relates, in general, to obesity, and, in particular, to a method of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide or other weight-loss promoting anticonvulsant either alone or in combination with bupropion or other compound that enhances the activity of norepinephrine and/or dopamine via uptake inhibition or other mechanism.
    Type: Application
    Filed: February 15, 2005
    Publication date: June 23, 2005
    Inventors: Kishore Gadde, K. Ranga Krishnan